| Serial Number | 97788558 |
| Word Mark | C2INFORM |
| Filing Date | Thursday, February 9, 2023 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, September 16, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 19, 2023 |
| Pseudo Mark | C TWO INFORM; C TO INFORM; CANCER TO INFORM |
| Goods and Services | Providing medical, disease, and cancer testing, detection, analysis, monitoring, and results reporting services, namely, medical testing for diagnostic or treatment purposes, medical analysis services relating to the treatment of patients, medical diagnostic testing, and monitoring and reporting services; medical testing for diagnostic or treatment purposes, namely, providing and performing genome sequencing of blood samples to health systems, oncologists, physicians, medical professionals, hospitals, and medical, disease, and cancer researchers, centers, clinics, and labs for diagnostic or treatment purposes; medical information and diagnostic test reporting services, namely, providing information and reports on patient's blood for minimal residual disease (MRD), cancer cells, and genetic-based diseases using whole genome sequencing for use by cancer patients, health systems, oncologists, physicians, medical professionals, hospitals, and medical, disease, and cancer researchers, centers, clinics, and labs |
| Goods and Services | Providing medical, disease, and cancer testing, detection, analysis, monitoring, and results reporting services, namely, providing medical testing services and information in the field of cancer research and disease classification; structural and functional analysis of genomes, namely, providing and performing genome sequencing of blood samples to health systems, oncologists, physicians, medical professionals, hospitals, and medical, disease, and cancer researchers, centers, clinics, and labs; Blood analysis services, namely, providing information and reports on patient's blood for minimal residual disease (MRD), cancer cells, and genetic-based diseases using whole genome sequencing for use by cancer patients, health systems, oncologists, physicians, medical professionals, hospitals, and medical, disease, and cancer researchers, centers, clinics, and labs; Software-as-a-Service (SaaS) services featuring non-downloadable computer software, non-downloadable computer applications, and web-based non-downloadable software and Platform-as-a-Service (PaaS) services feature computer software platforms in the nature of non-downloadable computer software, non-downloadable computer applications, and web-based non-downloadable software, all for accessing cloud-based servers and remote client servers for providing whole genome sequencing (WGS) medical testing results and reports, pre-surgical and post-surgical disease and cancer burden scores through bioinformatics and artificial intelligence, clinical analysis, and analyzing genetic patterns post-surgery |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, March 10, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, November 9, 2023 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | VERACYTE DIAGNOSTICS, LLC |
| Party Type | 21 - New Owner After Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | New York, NY 10014 |
| Party Name | C2i Genomics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10014 |
| Party Name | C2i Genomics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10014 |
| Event Date | Event Description |
| Monday, February 13, 2023 | NEW APPLICATION ENTERED |
| Friday, March 10, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, November 7, 2023 | ASSIGNED TO EXAMINER |
| Wednesday, November 8, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, November 8, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, November 8, 2023 | NON-FINAL ACTION WRITTEN |
| Wednesday, November 8, 2023 | NON-FINAL ACTION E-MAILED |
| Wednesday, November 8, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, November 9, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, November 14, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 29, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, December 19, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, December 19, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 13, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, July 11, 2024 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Tuesday, August 6, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, August 6, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, August 6, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Tuesday, August 6, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, August 6, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, September 16, 2024 | ABANDONMENT - NO USE STATEMENT FILED |
| Monday, September 16, 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |